Morning news brief: Biden backs India, Pfizer 95% effective, and more

WION Web Team
New Delhi, Delhi, IndiaUpdated: May 06, 2021, 09:00 AM IST

File photo of a healthcare professional prepares a dose of the Pfizer coronavirus disease (COVID-19) vaccine Photograph:(Reuters)

Story highlights

Good morning! Start your day with WION's daily news brief

US President Joe Biden has supported India's request for global waiver on patent protections for coronavirus vaccines in the pandemic, even though Washington feels intellectual property rights are important for businesses. Meanwhile, one of the largest study has found the Pfizer vaccine is 95 per cent effective against the virus, and these numbers significantly drop when only one of the two prescribed doses are taken.

Click on headlines to read more

The Biden administration on Wednesday decided to back the India-led fight for a global waiver on patent protections for coronavirus vaccines

The study found that the two shots of the vaccine provide 95.3 per cent protection against infection and 96.7 per cent protection against death seven days after the second dose.

As the grieving families started burying their loved ones after the crash, Obrador denied accusations made at him by the employers' association Coparmex, who claim the crash took place due to ignorance of repeated warnings and major cuts in the maintenance budget.